| NICE wants more information on olaparib before approving it Related items from OnMedica HRT short-term use raises risk of ovarian cancer, warns study Be alert to ovarian cancer, MDU warns GPs Blood test could boost early detection of ovarian cancer The pill could give long-term protection against womb cancer Cheap drugs promise reduction in breast cancer deaths |
Friday, 7 August 2015
Experts disappointed at NICE decision on ovarian cancer drug
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment